Hope for Brain Cancer: FAU Awarded Grants for Glioblastoma Treatment
FAU researchers are pioneering a new approach to treating glioblastoma - a highly aggressive brain cancer with one of the highest mortality rates - by targeting the gene MBLAC1 for the first time.
In Stereo: Neurons Shift Gears Between Thoughts Using Brain Rhythms
An FAU study provides a new understanding of how the brain organizes thoughts for navigation, memory and behavior - offering insights into neurological conditions like epilepsy, Alzheimer's and schizophrenia.
Fixing the Leak: An Opioid Treatment for Dopamine Disorders?
A breakthrough by FAU researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.
FAU, Cleveland Clinic Partner to Advance Biomedical Research Training
FAU's Stiles-Nicholson Brain Institute Hosts 'Brainy Days' Celebration
Florida 麻豆高清 University's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.
'Ding-Dong:' A Study Finds Specific Neurons With an Immune Doorbell
FAU neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.
FAU's Randy D. Blakely, Ph.D., Honored as a Prestigious ASPET Fellow
Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.
Dangers of the Metaverse and VR for U.S. Youth Revealed in New Study
A study is one of the first to explore experiencing harm in the metaverse among U.S. youth. Findings show a significant percentage reported experiencing many forms of harm in these spaces including bullying.
Master Copper Regulator Discovery May Offer Alzheimer's Clues
A groundbreaking study by FAU researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.
FAU Interim Vice President for Research Named Fulbright Specialist
Gregg Fields, Ph.D., was selected by the United States Department of State's Bureau of Educational and Cultural Affairs for his expertise and contributions in disease discovery and treatment.